Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Debt Ratio (2023 - 2025)

Goldenwell Biotech filings provide 3 years of Debt Ratio readings, the most recent being 0.5 for Q1 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.5 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.5, a N/A change, with the full-year FY2024 number at 0.43, up 28.66% from a year prior.
  • Debt Ratio hit 0.5 in Q1 2025 for Goldenwell Biotech, up from 0.43 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.5 in Q1 2025 to a low of 0.33 in Q4 2023.
  • Median Debt Ratio over the past 3 years was 0.43 (2024), compared with a mean of 0.42.
  • The widest YoY moves for Debt Ratio: up 28.66% in 2024, down 28.66% in 2024.
  • Goldenwell Biotech's Debt Ratio stood at 0.33 in 2023, then increased by 28.66% to 0.43 in 2024, then grew by 16.82% to 0.5 in 2025.
  • The last three reported values for Debt Ratio were 0.5 (Q1 2025), 0.43 (Q4 2024), and 0.33 (Q4 2023) per Business Quant data.